1 study found for:    17465990 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Irinotecan in Combination With Cisplatin in Pediatric Patients With Unfavorable Prognosis Gliomas
Condition: Pediatric High Risk Gliomas
Intervention: Drug: Combination of two marketed drugs (irinotecan and cisplatin)

Indicates status has not been verified in more than two years